Tim-3 expression by peripheral natural killer cells and natural killer T cells increases in patients with lung cancer - reduction after surgical resection

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 22, 2014, Pages 9945-9948

  Xu, Li Yun ^a   Chen, Dong Dong ^a   He, Jian Ying ^a   Lu, Chang Chang ^a   Liu, Xiao Guang ^a   Le, Han Bo ^a   Wang, Chao Ye ^a   Zhang, Yong Kui ^a  

^a Zhoushan Hospital   (China)

Author keywords

Flow cytometry; Lung cancer; Mucin domain 3; Natural killer cells; T cell immunoglobulin

Indexed keywords

HAVCR2 PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR MARKER;

CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNOLOGY; LUNG NEOPLASMS; MALE; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL; NATURAL KILLER T CELL; PATHOLOGY; PROGNOSIS;

CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NATURAL KILLER T-CELLS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84921496716     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.22.9945     Document Type: Article

References (16)

1. Anderson AC (2012). Tim-3, a negative regulator of anti-tumor immunity. Curr Opin Immunol, 24, 213-6.
2. Chiba S, Baghdadi M, Akiba H, et al (2012). Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol, 13, 832-42.
3. Da Silva IP, Gallois A, Jimenez-Baranda S, et al (2014). Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade. Cancer Immunol Res, 2, 410-22.
4. Gleason MK, Lenvik TR, McCullar V, et al (2012). Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galetin-9. Blood, 119, 3064-72.
5. Gao X, Zhu Y, Li G, et al (2012). Tim-3 expression characterizes regulatoy T cells in tumor tissues and is associated with lung cancer progression. PloS One, 7, 30676.
6. Hasegawa H, Yamashita K, Otubo D, et al (2014). Allogeneic DCG promote lung NK cell activation and antitumor effect after invariant NKT cell activation. Anticancer Res, 34, 3411-7.
7. Hodge G, Barnawi J, Jursevic, C, et al (2014). Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells. Clin Exp Immunol, 178, 79-85.
8. Ju Y, Hou N, Meng J, et al (2010). T cell immunoglobulin-and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol, 52, 322-9.
9. Liu Y, Shu Q, Gao L, et al (2010). Increased Tim-3 xpression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin Immunol, 137, 288-95.
10. Liu YC, Zhou SB, Gao F, et al (2013). Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-5.
11. Lu YY, Huang XE, Xu L, et al (2013). Potential predictors of sensitivity to pemetrexed as first-line chemotherapy for patients with advanced non-squamous NSCLCs. Asian Pac J Cancer Prev, 14, 2005-8.
12. Meggyes M, Miko E, Polgar B, et al (2014). Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy. PloS One, 9, 92371.
13. Ndhlovu LC, Lopez-Verges S, et al (2012). Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood, 119, 3734-43.
14. Wang WJ, Tao Z, Gu W, et al (2013). Variation of blood T lymphocyte subgroups in patients with non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 4671-3.
15. Wu W, Shi Y, Li S, Zhang Y, et al (2012). Blockade of Tim-3 signaling restores the virus-specific CD8+ T cell response in patients with chronic hepatitis B. Eur J Immunol, 42, 1180-91.
16. Yang X, Jiang X, Chen G, et al (2013). T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response. J Immunol, 190, 2068-79.